132 related articles for article (PubMed ID: 7351837)
1. A new approach in the immunotherapy of carcinoma of the colon and rectum.
Wallack MK
J Surg Oncol; 1980; 13(1):29-34. PubMed ID: 7351837
[TBL] [Abstract][Full Text] [Related]
2. A new approach in specific, active immunotherapy.
Wallack MK; Steplewski Z; Koprowski H; Rosato E; George J; Hulihan B; Johnson J
Cancer; 1977 Feb; 39(2):560-4. PubMed ID: 189895
[TBL] [Abstract][Full Text] [Related]
3. New concepts of cancer of the colon and rectum: immunotherapy for patients with cancer of the large intestine.
Griffen WO; Jewell WR; Meeker WR; Humphrey LJ
Dis Colon Rectum; 1972; 15(2):116-9. PubMed ID: 5026788
[No Abstract] [Full Text] [Related]
4. Immunotherapy in colorectal cancer.
Wallack MK
Mo Med; 1981 Jan; 78(1):23-5. PubMed ID: 7219405
[No Abstract] [Full Text] [Related]
5. Active specific adjuvant immunotherapy with vaccinia melanoma oncolysate.
Scoggin SD; Sivanandham M; Sperry RG; Wallack MK
Ann Plast Surg; 1992 Jan; 28(1):108-9. PubMed ID: 1642396
[TBL] [Abstract][Full Text] [Related]
6. Surgical adjuvant immunotherapy for colorectal cancer.
Enker WE; Jacobitz JL; Craft K; Wissler RW
J Surg Oncol; 1978; 10(5):389-97. PubMed ID: 732327
[TBL] [Abstract][Full Text] [Related]
7. Improved immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination with interleukin-2.
McLaughlin JP; Schlom J; Kantor JA; Greiner JW
Cancer Res; 1996 May; 56(10):2361-7. PubMed ID: 8625312
[TBL] [Abstract][Full Text] [Related]
8. A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma.
Wallack MK; Sivanandham M; Balch CM; Urist MM; Bland KI; Murray D; Robinson WA; Flaherty LE; Richards JM; Bartolucci AA
Cancer; 1995 Jan; 75(1):34-42. PubMed ID: 7804974
[TBL] [Abstract][Full Text] [Related]
9. Melbourne trial of adjuvant immunotherapy in operable large bowel cancer.
Gray BN; Walker C; Andrewartha L; Freeman S; Bennett RC
Aust N Z J Surg; 1988 Jan; 58(1):43-6. PubMed ID: 3046593
[TBL] [Abstract][Full Text] [Related]
10. The immunobiology of colorectal cancer.
Mcdonald JS
Semin Oncol; 1976 Dec; 3(4):421-31. PubMed ID: 793017
[No Abstract] [Full Text] [Related]
11. Active specific immunotherapy of Dukes B2 and C colorectal carcinoma: comparison of two doses of the vaccine.
Jessup JM; McBride CM; Ames FC; Guarda L; Ota DM; Romsdahl MM; Martin RG
Cancer Immunol Immunother; 1986; 21(3):233-9. PubMed ID: 2938738
[TBL] [Abstract][Full Text] [Related]
12. Colon carcinoma and immunologic phenomena.
Griffen WO; Meeker WR
Surg Clin North Am; 1972 Aug; 52(4):839-46. PubMed ID: 5047526
[No Abstract] [Full Text] [Related]
13. Active specific immunotherapy and immunochemotherapy in the treatment of lung and colon cancer.
Hollinshead A
Semin Surg Oncol; 1991; 7(4):199-210. PubMed ID: 1925251
[TBL] [Abstract][Full Text] [Related]
14. Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer.
Hoover HC; Surdyke MG; Dangel RB; Peters LC; Hanna MG
Cancer; 1985 Mar; 55(6):1236-43. PubMed ID: 3882219
[TBL] [Abstract][Full Text] [Related]
15. Active specific immunotherapy for metastatic colorectal carcinoma: phase I study of an allogeneic cell vaccine plus low-dose interleukin-1 alpha.
Woodlock TJ; Sahasrabudhe DM; Marquis DM; Greene D; Pandya KJ; McCune CS
J Immunother; 1999 May; 22(3):251-9. PubMed ID: 10335485
[TBL] [Abstract][Full Text] [Related]
16. Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A.
Liljefors M; Nilsson B; Hjelm Skog AL; Ragnhammar P; Mellstedt H; Frödin JE
Int J Cancer; 2003 Jul; 105(5):717-23. PubMed ID: 12740924
[TBL] [Abstract][Full Text] [Related]
17. [Surgical treatment of colorectal cancer. Value of immunologic competence skin tests in the prognostic and immunotherapeutic evaluation].
de Godoy AC; Crema E; Goffi FS; Aun WC; Salles VL; de Mello JF
Rev Paul Med; 1983; 101(3):91-5. PubMed ID: 6648227
[No Abstract] [Full Text] [Related]
18. Active specific immunotherapy with antiidiotypic antibodies in patients with solid tumors.
O'Connell MJ; Chen ZJ; Yang H; Yamada M; Massaro M; Mittelman A; Ferrone S
Semin Surg Oncol; 1989; 5(6):441-7. PubMed ID: 2688034
[TBL] [Abstract][Full Text] [Related]
19. A trial of 5-fluorouracil and Corynebacterium parvum in advanced colorectal carcinoma.
Gough IR; Clunie GJ; Bolton PM; Dury M; Burnett W
Dis Colon Rectum; 1979; 22(4):223-7. PubMed ID: 313873
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of cancer: current status.
Goodnight JE; Morton DL
Prog Exp Tumor Res; 1980; 25():61-88. PubMed ID: 6986637
[No Abstract] [Full Text] [Related]
[Next] [New Search]
